JEST
GSK icon

JTC Employer Solutions Trustee’s GSK GSK Stock Holding History

JTC Employer Solutions Trustee’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$450M Sell
8,592,987
-449,402
-5% -$23.8M 36.11% 1
2026
Q1 		$499M Sell
9,042,389
-5,385,620
-37% -$292M 41.69% 1
2025
Q4 		$708M Sell
14,428,009
-169,176
-1% -$7.89M 48.05% 1
2025
Q3 		$630M Sell
14,597,185
-400,199
-3% -$15.6M 54.03% 1
2025
Q2 		$576M Sell
14,997,384
-262,984
-2% -$10M 54.9% 1
2025
Q1 		$592M Sell
15,260,368
-5,018,196
-25% -$184M 48.6% 1
2024
Q4 		$682M Sell
20,278,564
-202,398
-1% -$7.29M 48.38% 1
2024
Q3 		$837M Sell
20,480,962
-399,462
-2% -$16.3M 54.67% 1
2024
Q2 		$804M Sell
20,880,424
-260,588
-1% -$11M 53.74% 1
2024
Q1 		$909M Buy
21,141,012
+8,800,822
+71% +$363M 57.69% 1
2023
Q4 		$458M Sell
12,340,190
-104,270
-0.8% -$3.74M 41.35% 1
2023
Q3 		$451M Sell
12,444,460
-1,286,460
-9% -$45.7M 41.96% 1
2023
Q2 		$489M Sell
13,730,920
-262,288
-2% -$9.41M 46.61% 1
2023
Q1 		$498M Sell
13,993,208
-3,978,762
-22% -$139M 52.83% 1
2022
Q4 		$631M Buy
17,971,970
+13,264,687
+282% +$442M 54.05% 1
2022
Q3 		$139M Sell
4,707,283
-2,253,289
-32% -$85.4M 23.02% 1
2022
Q2 		$379M Sell
6,960,572
-253,004
-4% -$14M 49.49% 1
2022
Q1 		$393M Buy
7,213,576
+2,418,907
+50% +$131M 43.49% 1
2021
Q4 		$264M Sell
4,794,669
-264,786
-5% -$13.8M 32.64% 1
2021
Q3 		$242M Sell
5,059,455
-873,139
-15% -$43.9M 32.36% 1
2021
Q2 		$295M Buy
+5,932,594
New +$285M 43.57% 1

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JTC Employer Solutions Trustee's GSK Position: Q2 2026 in Review

JTC Employer Solutions Trustee reduced its GSK (GSK) stake by 5% in Q2 2026, selling an estimated $23.8M and leaving 8,592,987 shares worth $450M. The position accounts for 36.11% of the portfolio, ranked #1.

JTC Employer Solutions Trustee first reported a position in GSK in Q2 2021 and has held it in 21 quarters since. The position peaked at $909M in Q1 2024. 1,039 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • JTC Employer Solutions Trustee held 8,592,987 shares of GSK worth $450M as of Q2 2026.
  • JTC Employer Solutions Trustee sold 449,402 GSK shares in Q2 2026, an estimated $23.8M.
  • GSK made up 36.11% of JTC Employer Solutions Trustee's portfolio in Q2 2026, its #1 holding.
  • JTC Employer Solutions Trustee first reported a position in GSK in Q2 2021 and has held it in 21 quarters since.
  • JTC Employer Solutions Trustee's GSK position peaked at $909M in Q1 2024.
  • 1,039 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on JTC Employer Solutions Trustee's 13F filing for Q2 2026, filed 31 Jul 2026.